141 related articles for article (PubMed ID: 18754324)
21. Alteration of Homeostasis in Pre-osteoclasts Induced by Aggregatibacter actinomycetemcomitans CDT.
Kawamoto D; Ando-Suguimoto ES; Bueno-Silva B; DiRienzo JM; Mayer MP
Front Cell Infect Microbiol; 2016; 6():33. PubMed ID: 27064424
[TBL] [Abstract][Full Text] [Related]
22. [Osteoprotegerin and receptor activator of nuclear factor kappa B ligand mRNAs expression in BMSCs of glucocorticoid-induced necrosis of the femoral head patients].
Wang J; Gao H; Wang K; Li W; Shi Z; Zhang M
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Jul; 23(7):777-80. PubMed ID: 19662974
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis.
Giannopoulou C; Martinelli-Klay CP; Lombardi T
Acta Odontol Scand; 2012 Dec; 70(6):629-34. PubMed ID: 22214279
[TBL] [Abstract][Full Text] [Related]
24. Resistance of human periodontal ligament fibroblasts to the cytolethal distending toxin of Actinobacillus actinomycetemcomitans.
Kanno F; Korostoff J; Volgina A; DiRienzo JM
J Periodontol; 2005 Jul; 76(7):1189-201. PubMed ID: 16018764
[TBL] [Abstract][Full Text] [Related]
25. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
Ikeda T; Utsuyama M; Hirokawa K
J Bone Miner Res; 2001 Aug; 16(8):1416-25. PubMed ID: 11499864
[TBL] [Abstract][Full Text] [Related]
26. Expression and Distribution of Receptor Activator of Nuclear Factor Kappa B, Receptor Activator of Nuclear Factor Kappa B Ligand, and Osteoprotegerin in Periradicular Cysts.
Armada L; Marotta Pdos S; Pires FR; Siqueira JF
J Endod; 2015 Aug; 41(8):1281-7. PubMed ID: 25956608
[TBL] [Abstract][Full Text] [Related]
27. Immune-Inflammatory Cell Profile and Receptor Activator of Nuclear Factor Kappa B Ligand/Osteoprotegerin Expression in Persistent Apical Periodontitis after Root Canal Retreatment Failure.
Estrela C; Decurcio Dde A; Silva JA; Batista AC; de Souza Lima NC; de Freitas Silva BS; de Souza JA; Souza Costa CA
J Endod; 2016 Mar; 42(3):439-46. PubMed ID: 26806398
[TBL] [Abstract][Full Text] [Related]
28. Expression of the cytolethal distending toxin (Cdt) operon in Actinobacillus actinomycetemcomitans: evidence that the CdtB protein is responsible for G2 arrest of the cell cycle in human T cells.
Shenker BJ; Hoffmaster RH; McKay TL; Demuth DR
J Immunol; 2000 Sep; 165(5):2612-8. PubMed ID: 10946289
[TBL] [Abstract][Full Text] [Related]
29. RANK/RANKL/OPG system in the intervertebral disc.
Takegami N; Akeda K; Yamada J; Sano T; Murata K; Huang J; Masuda K; Sudo A
Arthritis Res Ther; 2017 Jun; 19(1):121. PubMed ID: 28576140
[TBL] [Abstract][Full Text] [Related]
30. Toxicity and immunogenicity of purified Haemophilus ducreyi cytolethal distending toxin in a rabbit model.
Wising C; Svensson LA; Ahmed HJ; Sundaeus V; Ahlman K; Jonsson IM; Mölne L; Lagergård T
Microb Pathog; 2002 Aug; 33(2):49-62. PubMed ID: 12202104
[TBL] [Abstract][Full Text] [Related]
31. The RANKL-OPG system is differentially regulated by supragingival and subgingival biofilm supernatants.
Belibasakis GN; Meier A; Guggenheim B; Bostanci N
Cytokine; 2011 Jul; 55(1):98-103. PubMed ID: 21474331
[TBL] [Abstract][Full Text] [Related]
32. Atorvastatin Reduces Circulating Osteoprogenitor Cells and T-Cell RANKL Expression in Osteoporotic Women: Implications for the Bone-Vascular Axis.
Rattazzi M; Faggin E; Buso R; Di Virgilio R; Puato M; Plebani M; Zaninotto M; Palmosi T; Bertacco E; Fadini GP; Pauletto P
Cardiovasc Ther; 2016 Feb; 34(1):13-20. PubMed ID: 26506085
[TBL] [Abstract][Full Text] [Related]
33. Interactions of Haemophilus ducreyi and purified cytolethal distending toxin with human monocyte-derived dendritic cells, macrophages and CD4+ T cells.
Xu T; Lundqvist A; Ahmed HJ; Eriksson K; Yang Y; Lagergård T
Microbes Infect; 2004 Nov; 6(13):1171-81. PubMed ID: 15488736
[TBL] [Abstract][Full Text] [Related]
34. Perinuclear localization of internalized outer membrane vesicles carrying active cytolethal distending toxin from Aggregatibacter actinomycetemcomitans.
Rompikuntal PK; Thay B; Khan MK; Alanko J; Penttinen AM; Asikainen S; Wai SN; Oscarsson J
Infect Immun; 2012 Jan; 80(1):31-42. PubMed ID: 22025516
[TBL] [Abstract][Full Text] [Related]
35. LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin.
Nagasawa T; Kobayashi H; Kiji M; Aramaki M; Mahanonda R; Kojima T; Murakami Y; Saito M; Morotome Y; Ishikawa I
Clin Exp Immunol; 2002 Nov; 130(2):338-44. PubMed ID: 12390325
[TBL] [Abstract][Full Text] [Related]
36. Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats.
Lu J; Liu F; Liu D; Du H; Hao J; Yang X; Cui W
Exp Biol Med (Maywood); 2016 Jun; 241(11):1237-49. PubMed ID: 26908571
[TBL] [Abstract][Full Text] [Related]
37. Actinobacillus actinomycetemcomitans cytolethal distending toxin (Cdt): evidence that the holotoxin is composed of three subunits: CdtA, CdtB, and CdtC.
Shenker BJ; Besack D; McKay T; Pankoski L; Zekavat A; Demuth DR
J Immunol; 2004 Jan; 172(1):410-7. PubMed ID: 14688349
[TBL] [Abstract][Full Text] [Related]
38. The mechanism of Jurkat cells apoptosis induced by Aggregatibacter actinomycetemcomitans cytolethal distending toxin.
Chen HP; Li L; Chen X; Yang MF; Ye Y; Wang XQ; Xu Y
Apoptosis; 2017 Jun; 22(6):841-851. PubMed ID: 28247205
[TBL] [Abstract][Full Text] [Related]
39. Heme oxygenase-1 protects human periodontal ligament cells against substance P-induced RANKL expression.
Lee HJ; Jeong GS; Pi SH; Lee SI; Bae WJ; Kim SJ; Lee SK; Kim EC
J Periodontal Res; 2010 Jun; 45(3):367-74. PubMed ID: 20337895
[TBL] [Abstract][Full Text] [Related]
40. Production of Soluble Receptor Activator of Nuclear Factor Kappa-Β Ligand and Osteoprotegerin by Apical Periodontitis Cells in Culture and Their Modulation by Cytokines.
Duka M; Eraković M; Dolićanin Z; Stefanović D; Čolić M
Mediators Inflamm; 2019; 2019():8325380. PubMed ID: 31011287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
